Desirudin Subcutaneous and Lithium Controlled-Release and Extended-Release Tablets
Determining the interaction of Desirudin Subcutaneous and Lithium Controlled-Release and Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: desirudin
Brand name: Iprivask
Synonyms: Desirudin
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Desirudin Subcutaneous-Lithium ER
- Desirudin Subcutaneous-Lithium Oral Solution
- Desirudin Subcutaneous-Lithium Salts
- Desirudin Subcutaneous-Lithium Syrup and Oral Solution
- Desirudin Subcutaneous-Lithobid
- Desirudin Subcutaneous-Lithostat
- Lithium Controlled-Release and Extended-Release Tablets-Desloratadine
- Lithium Controlled-Release and Extended-Release Tablets-Desloratadine and pseudoephedrine
- Lithium Controlled-Release and Extended-Release Tablets-Desloratadine Oral Solution
- Lithium Controlled-Release and Extended-Release Tablets-Desloratadine Orally Disintegrating Tablets
- Lithium Controlled-Release and Extended-Release Tablets-Desloratadine Syrup
- Lithium Controlled-Release and Extended-Release Tablets-Desloratadine Tablets